Search
28/10/2025
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial
Laudani, C, Ortega-Paz, L, Sionis, A, Calés, PV, Arevalos, V, Riba, RA, Morr, C, De Diego, O, Ortega, E, Dantas, AP, Angiolillo, D, Sabate, M, Ortiz-Pérez, JT, Brugaletta, S. Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction: the DAPA-STEMI Trial. JACC-JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 2025; 86(17)DOI:. PMID:. IF:22.300(Q1/1D).
28/10/2025
POINTER: study protocol for a phase 2b, randomised, placebo-controlled, double-blind, parallel group dose-finding clinical study to evaluate the efficacy of RMC-035 on renal function and safety, in participants at high risk for kidney injury, following open-chest cardiac surgery
Zarbock, A, Strauss, C, Laflamme, M, Myjavec, A, Böhm, J, Burkert, J, Mazer, CD, de Varennes, B, Ginel Iglesias, A, Matschke, K, Larsson, TE, Reusch, M. POINTER: study protocol for a phase 2b, randomised, placebo-controlled, double-blind, parallel group dose-finding clinical study to evaluate the efficacy of RMC-035 on renal function and safety, in participants at high risk for kidney injury, following open-chest cardiac surgery. Trials. 2025; 26(1)DOI:10.1186/s13063-025-09124-x. PMID:41152991. IF:2.000(Q3/7D).
25/10/2025
Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly
Araujo-Castro, M, García-Centeno, R, González, L, Nobre, EL, Severino, MD, Goi, J, Pena, MMP, Torre, EM, Aida, CL, Novoa-Testa, I, Cordido, F, Sánchón, R, Guerrero-Pérez, F, Rodríguez, RO, Rodríguez-Jiménez, B, García, MDO, Echarri, AI, Simó-Servat, A, Rodríguez, MDM, Novo-Rodríguez, C, Calatayud, M, Villar-Taibo, R, Bernabéu, I, Tenorio-Jimenéz, C, Molero, IG, Iglesias, P, Blanco, C, De Lara, FVO, Aulinas, A, Roca, QA, Fano, MP, Martínez, AR, Cardoso, LM, Marques, P, Giustina, A, Marazuela, M, Puig-Domingo, M, Biagetti, B. Prevalence and evolution of hypertension in a large Iberian cohort of patients with acromegaly. Pituitary. 2025; 28(6)DOI:10.1007/s11102-025-01586-1. PMID:41139153. IF:3.400(Q2/4D).
25/10/2025
Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain
Araujo-Castro, M, García-Centeno, R, González, L, Hanzu, FA, Orois, A, Camara, R, García, MDO, Echarri, AI, Gimeno, PG, Pascual-Corrales, E, Biagetti, B, Cardona, A, Molero, IG, Simo-Servat, A, Pérez, FG, Villar-Taibo, R, Bernabéu, I, Fajardo-Montañana, C, Novo-Rodríguez, C, Jimenéz, CT, Calatayud, M, Rodríguez, MDM, Cordido, F, Castro, A, Valero, LM, Fano, MP, Goi, J, Aulinas, A, Abellán, P, Iglesias, P, Soto-Moreno, A. Real-World Data on the Efficacy and Safety of Osilodrostat in Patients with Cushing's Disease in Spain. Journal of Clinical Medicine. 2025; 14(21)DOI:10.3390/jcm14217575. PMID:41226972. IF:2.900(Q1/2D).